PubRank

J Keski-Oja

Author PubWeight™ 130.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp Med 1987 4.35
2 Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol 1988 4.34
3 Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. J Clin Invest 1987 2.74
4 Growth factors in the extracellular matrix. FASEB J 1997 2.71
5 Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta. J Cell Biol 1986 2.44
6 Latent transforming growth factor-beta binding proteins (LTBPs)--structural extracellular matrix proteins for targeting TGF-beta action. Cytokine Growth Factor Rev 1999 2.22
7 Dimeric character of fibronectin, a major cell surface-associated glycoprotein. Biochem Biophys Res Commun 1977 2.18
8 Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein. J Cell Biol 1994 2.15
9 Induction of fibroblast chemotaxis by fibronectin. Localization of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment. J Exp Med 1981 2.10
10 Transforming growth factor-beta induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase. J Biol Chem 1987 2.05
11 Specific sequence motif of 8-Cys repeats of TGF-beta binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-beta. Mol Biol Cell 2000 2.01
12 Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis. Proc Natl Acad Sci U S A 2001 1.83
13 Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils. J Histochem Cytochem 1996 1.79
14 Active and latent forms of transforming growth factor beta activity in synovial effusions. J Exp Med 1989 1.77
15 Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation. Mol Cell Biol 1989 1.70
16 Latency, activation, and binding proteins of TGF-beta. Microsc Res Tech 2001 1.70
17 Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells. J Biol Chem 1991 1.68
18 Transforming growth factors and control of neoplastic cell growth. J Cell Biochem 1987 1.67
19 Cross-linking of a major fibroblast surface-associated glycoprotein (fibronectin) catalyzed by blood coagulation factor XIII. Cell 1976 1.64
20 Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial and endothelial cells. J Biol Chem 1995 1.61
21 Growth factors in the regulation of pericellular proteolysis: a review. Cancer Res 1989 1.55
22 Release of transforming growth factor-beta 1 from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin. J Biol Chem 1992 1.50
23 Association of the small latent transforming growth factor-beta with an eight cysteine repeat of its binding protein LTBP-1. EMBO J 1996 1.50
24 Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface. Biochem J 1998 1.48
25 Extracellular matrix-associated transforming growth factor-beta: role in cancer cell growth and invasion. Adv Cancer Res 1998 1.48
26 Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas. Br J Cancer 1999 1.38
27 Impaired migration and delayed differentiation of pancreatic islet cells in mice lacking EGF-receptors. Development 2000 1.38
28 Structural analysis and promoter characterization of the human membrane-type matrix metalloproteinase-1 (MT1-MMP) gene. Gene 2000 1.37
29 Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain. J Biol Chem 2000 1.36
30 The cellular response to induction of the p21 c-Ha-ras oncoprotein includes stimulation of jun gene expression. EMBO J 1989 1.35
31 Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur J Biochem 1996 1.35
32 Transforming growth factor beta alters plasminogen activator activity in human skin fibroblasts. Exp Cell Res 1986 1.32
33 Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells--role in metastasis. Int J Cancer 1982 1.31
34 Murine sarcoma growth factors affect the growth and morphology of cultured mouse epithelial cells. J Cell Physiol 1980 1.30
35 Direct association of fibronectin and actin molecules in vitro. J Cell Biol 1980 1.28
36 Identification and characterization of a new latent transforming growth factor-beta-binding protein, LTBP-4. J Biol Chem 1998 1.24
37 Fibroblast surface antigen (SF): molecular properties, distribution in vitro and in vivo, and altered expression in transformed cells. J Supramol Struct 1976 1.23
38 Latent TGF-beta binding protein LTBP-1 contains three potential extracellular matrix interacting domains. J Cell Sci 2001 1.23
39 Activation of paracrine TGF-beta1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase. FASEB J 2001 1.22
40 Interaction of viral envelope glycoproteins with fibronectin. Infect Immun 1983 1.21
41 Transforming growth factor beta regulation of cell proliferation. J Cell Physiol Suppl 1987 1.18
42 Distribution of a major surface-associated glycoprotein, fibronectin, in cultures of adherent cells. J Supramol Struct 1977 1.18
43 1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Differ 2000 1.14
44 Independent promoters regulate the expression of two amino terminally distinct forms of latent transforming growth factor-beta binding protein-1 (LTBP-1) in a cell type-specific manner. J Biol Chem 1999 1.12
45 Pericellular substrates of human mast cell tryptase: 72,000 dalton gelatinase and fibronectin. J Cell Biochem 1992 1.12
46 The cellular target for the plasminogen activator, urokinase, in human fibroblasts - 66 000 dalton protein. Biochim Biophys Acta 1982 1.09
47 Pachydermoperiostosis: analysis of the connective tissue abnormality in one family. J Am Acad Dermatol 1994 1.04
48 Dose effects of transfected c-Ha-rasVal 12 oncogene in transformed cell clones. Exp Cell Res 1987 1.04
49 Gremlin localization and expression levels partially differentiate idiopathic interstitial pneumonia severity and subtype. J Pathol 2008 1.02
50 Interaction of fibronectin with complement component C3. Scand J Immunol 1983 1.01
51 Calcium ionophores decrease pericellular gelatinolytic activity via inhibition of 92-kDa gelatinase expression and decrease of 72-kDa gelatinase activation. J Biol Chem 1995 1.01
52 Extracellular matrix proteins characterize human tumor cell lines. Int J Cancer 1981 1.00
53 Promoter characterization of the human and mouse epilysin (MMP-28) genes. Gene 2001 0.96
54 Isolation of an actin-binding fragment of fibronectin. Biochem J 1981 0.95
55 Rapid membrane changes in mouse epithelial cells after exposure to epidermal growth factor. J Ultrastruct Res 1981 0.94
56 Cutis laxa in hereditary gelsolin amyloidosis. Br J Dermatol 2005 0.93
57 Recombinant latent transforming growth factor beta-binding protein 2 assembles to fibroblast extracellular matrix and is susceptible to proteolytic processing and release. J Biol Chem 1998 0.93
58 Keratin filaments of mouse epithelial cells are rapidly affected by epidermal growth factor. J Cell Biol 1981 0.92
59 Fibronectin and the pericellular matrix of normal and transformed adherent cells. Ann N Y Acad Sci 1978 0.91
60 Fibroblast surface antigen (SF): the external glycoprotein lost in proteolytic stimulation and maligant transfromation. Int J Cancer 1976 0.91
61 Affinity of myeloma IgG proteins for fibronectin. Clin Exp Immunol 1983 0.90
62 Ovarian thecal cells produce transforming growth factor-beta which can regulate granulosa cell growth. Endocrinology 1987 0.90
63 Transforming growth factor beta 1 and its latent form binding protein-1 associate with elastic fibres in human dermis: accumulation in actinic damage and absence in anetoderma. Br J Dermatol 1997 0.90
64 1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells. Cancer Res 1995 0.90
65 Transforming growth factors-beta as regulators of cellular growth and phenotype. Crit Rev Oncog 1992 0.89
66 Endostatin-induced modulation of plasminogen activation with concomitant loss of focal adhesions and actin stress fibers in cultured human endothelial cells. Cancer Res 2001 0.89
67 Hepatocyte growth factor releases epithelial and endothelial cells from growth arrest induced by transforming growth factor-beta1. J Biol Chem 1996 0.88
68 Thrombin affects fibronectin and procollagen in the pericellular matrix of cultured human fibroblasts. Biochim Biophys Acta 1981 0.88
69 Okadaic acid-elicited transcriptional activation of collagenase gene expression in HT-1080 fibrosarcoma cells is mediated by JunB. Cell Growth Differ 1994 0.86
70 Establishment and characterization of the epithelial mouse embryo cell line MMC-E. Cancer Res 1979 0.86
71 Acute myelogenous leukaemia with c-myc amplification and double minute chromosomes. Lancet 1985 0.86
72 TGF-beta 1 modulation of urokinase and PAI-1 expression in human bronchial epithelial cells. Am J Physiol 1990 0.86
73 Novel non-TGF-beta-binding splice variant of LTBP-4 in human cells and tissues provides means to decrease TGF-beta deposition. J Cell Sci 2001 0.85
74 Truncal telangiectases coinciding with felodipine. Dermatology 1998 0.85
75 Epidermal growth factor-induced alterations in proliferating mouse epithelial cells. Exp Cell Res 1980 0.85
76 Localization of viral-envelope-glycoprotein-binding sites in fibronectin. Biochem J 1984 0.84
77 C3c and C3d fragments of human C3 bind myeloma IgG1 and IgG3 proteins. Immunol Lett 1982 0.84
78 Specific effects of fibronectin-releasing peptides on the extracellular matrices of cultured human fibroblasts. Cancer Res 1980 0.82
79 Structure and expression of type IV collagenase genes. Cell Differ Dev 1990 0.82
80 Induction of transforming growth factor beta 1 and its receptor expression during myeloid leukemia cell differentiation. Cell Growth Differ 1994 0.82
81 Cerebrospinal fluid IgG bands and virus-specific IgG, IgM, and IgA antibodies in herpes simplex virus encephalitis. J Neuroimmunol 1982 0.82
82 Rapid release of fibronectin from human lung fibroblasts by biologically active phorbol esters. Int J Cancer 1979 0.82
83 Transformation of MMC-E epithelial cells by acute 3611-MSV: inhibition of collagen synthesis and induction of novel polypeptides. J Cell Biochem 1982 0.81
84 Growth inhibitory polypeptides in the regulation of cell proliferation. Med Biol 1987 0.81
85 Enhancement of vitronectin expression in human HepG2 hepatoma cells by transforming growth factor-beta 1. Eur J Biochem 1991 0.81
86 Apoptosis of human endothelial cells is accompanied by proteolytic processing of latent TGF-beta binding proteins and activation of TGF-beta. Cell Death Differ 2005 0.81
87 Vitamin D3 regulation of transforming growth factor-beta system in epithelial and fibroblastic cells--relationships to plasminogen activation. J Investig Dermatol Symp Proc 1996 0.81
88 Cyclosporin A enhances cytokine and phorbol ester-induced fibroblast collagenase expression. J Invest Dermatol 1994 0.81
89 Polymerization of a major surface-associated glycoprotein, fibronectin, in cultured fibroblasts. FEBS Lett 1976 0.80
90 Transforming growth factor-beta system and its regulation by members of the steroid-thyroid hormone superfamily. Adv Cancer Res 1996 0.80
91 Hepatocyte growth factor releases mink epithelial cells from transforming growth factor beta1-induced growth arrest by restoring Cdk6 expression and cyclin E-associated Cdk2 activity. Mol Cell Biol 1999 0.80
92 Effects of Zn2+ ions on protein phosphorylation in epithelial cell membranes. J Cell Physiol 1983 0.80
93 Loss of different pericellular matrix components of rat cells transformed with a T-class ts mutant of Rous sarcoma virus. Virology 1982 0.80
94 Regulation of plasminogen activator activity in human fibroblastic cells by fibrosarcoma cell-derived factors. Cancer Res 1985 0.79
95 Vitamin D receptor polymorphism and treatment of psoriasis with calcipotriol. Br J Dermatol 1997 0.79
96 Down-regulation of transforming growth factor-beta receptors I and II is seen in lesional but not non-lesional psoriatic epidermis. Br J Dermatol 1998 0.79
97 Growth control in chick embryo fibroblasts; no evidence for a specific role for cyclic purine nucleotides. Cell 1974 0.79
98 Binding of fibronectin to actin is inhibited by gelatin. Biochem Biophys Res Commun 1981 0.79
99 Characterization and purification of a secreted plasminogen activator inhibitor (PAI-1) induced by transforming growth factor-beta 1 in normal rat kidney (NRK) cells: decreased PAI-1 expression in transformed NRK cells. Endocrinology 1990 0.78
100 Growth stimulation, altered regulation of epidermal growth factor receptors, and autocrine transformation of spontaneously transformed normal rat kidney cells by transforming growth factor beta. Cancer Res 1989 0.78
101 Characterization of a novel gelatin-binding 21 kDa protein secreted by cultured adherent cells. Biochim Biophys Acta 1986 0.78
102 Vitamin D3 and calcipotriol enhance the secretion of transforming growth factor-beta 1 and -beta 2 in cultured murine keratinocytes. Growth Factors 1993 0.78
103 Cellular senescence. Ann Med 1992 0.78
104 Reorganization of plasma membrane-associated 36 000 dalton protein upon drug-induced redistribution of cytokeratin. Exp Cell Res 1985 0.76
105 Expression and purification of soluble and inactive mutant forms of membrane type 1 matrix metalloproteinase. Protein Expr Purif 2000 0.76
106 Vitamin D3 derivatives (deltanoids) in the treatment of tumor cell invasion. J Lab Clin Med 1999 0.75
107 Isolation of Chlamydia trachomatis in Untreated MMC-E mouse epithelial cells. J Clin Microbiol 1982 0.75
108 Single-serum radial hemolysis to detect recent rubella virus infection. J Infect Dis 1986 0.75
109 Transformation of cultured epithelial cells by ethylnitrosourea. Altered expression of type I procollagen chains. Biochim Biophys Acta 1984 0.75
110 Murine leukemia virus-mediated transformation of a mouse epithelial cell line MMC-E. Cancer Res 1982 0.75
111 Human ectocervical and endocervical epithelial cells in culture: a comparative ultrastructural study. Am J Obstet Gynecol 1980 0.75
112 Synthesis and degradation of connective tissue macromolecules in pachydermoperiostosis (PDP): evidence for altered processing of plasminogen activator inhibitor-1 (PAI-1). Exp Dermatol 1995 0.75
113 Risk of hepatitis B in a ward for mentally retarded HBsAg carriers. Infection 1986 0.75
114 Transforming growth factor-beta does not alter interleukin-1 expression in cultured human macrophages. J Cell Biochem 1989 0.75
115 [Transforming growth factor-beta and malignant growth]. Duodecim 1986 0.75
116 [The stages of cell growth]. Duodecim 1990 0.75
117 Inhibition of morphogenesis and stimulation of vascular proliferation in embryonic tooth cultures by a sarcoma growth factor preparation. Cancer Res 1983 0.75
118 Human platelet-derived growth factor preparations contain a separate activity which potentiates follicle-stimulating hormone-mediated induction of luteinizing hormone receptor in cultured rat granulosa cells: evidence for transforming growth factor-beta. Endocrinology 1988 0.75
119 MMC-E cells--origin and changes in karyotype accompanying malignant transformation. Cancer Genet Cytogenet 1985 0.75
120 [Polypeptide growth factors from malignant cells]. Duodecim 1981 0.75
121 [Fibronectin: a connective tissue and plasma glycoprotein]. Duodecim 1978 0.75
122 Hypoxia, normoxia and hyperoxia--terminology for medical in vitro cell biology. Acta Oncol 2000 0.75
123 Distribution of the 36 000 dalton tyrosine protein kinase substrate in drug and epidermal growth factor-treated epithelial cells. Exp Cell Res 1984 0.75
124 [Growth factors and post-injury tissue repair]. Duodecim 1988 0.75
125 Human fibrosarcoma cells produce fibronectin-releasing peptides. J Supramol Struct 1979 0.75
126 [Tetracyclines as anti-inflammatory treatment in skin diseases]. Nord Med 1996 0.75
127 Pericellular matrix and cell surface glycoproteins of virus-transformed mouse epithelial cells. Cancer Res 1982 0.75
128 Vitamin D3 and calcipotriol decrease extracellular plasminogen activator activity in cultured keratinocytes. J Invest Dermatol 1993 0.75
129 Micromethod for detection of oligoclonal IgG in unconcentrated CSF by polyacrylamide gel electrophoresis. Arch Neurol 1981 0.75